Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
assays
MedTech
Thermo Fisher launches biopsy test to assess lung rejection risk
With Thermo Fisher’s new test, physicians can estimate the likelihood of rejection using molecular scores tied to injury and graft dysfunction.
Joseph Keenan
Oct 9, 2025 10:50am
Merck KGaA rolls out ‘all-in-one’ CHO genetic stability assay
Apr 18, 2024 4:05pm
Alzheimer's test could diagnose 'disease of exclusion' earlier
Dec 6, 2022 11:25am
Worldwide CRO expands with new bioanalytical lab
Aug 23, 2022 8:35am
PPD expands lab test work to boost pandemic trials
Jun 29, 2020 7:35am
10x Genomics debuts gene expression mapping tech
Nov 26, 2019 9:00am
